Showing results (571-580 of 589) with videos related to

Sort By:
Pageof 59
The Journal of Clinical Endocrinology and Metabolism|May 5, 2022
Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 CasesIulia Potorac, Jean-François Bonneville, Adrian F Daly, et al.
Nature Immunology|February 5, 2025
The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancerJiacheng He, Xiaolei Chai, Qiansen Zhang, et al.
Nature Reviews. Endocrinology|June 24, 2025
Pituitary incidentaloma: a Pituitary Society international consensus guideline statementMaria Fleseriu, Mark Gurnell, Ann McCormack, et al.
American Journal of Human Genetics|July 16, 2021
High-throughput splicing assays identify missense and silent splice-disruptive POU1F1 variants underlying pituitary hormone deficiencyPeter Gergics, Cathy Smith, Hironori Bando, et al.
Carcinogenesis|December 28, 2016
Prevalence of HPV Infection in Racial-Ethnic Subgroups of Head and Neck Cancer PatientsCamille Ragin, Jeffrey C Liu, Gieira Jones, et al.
Endocrine-Related Cancer|July 28, 2010
Systematic comparison of sporadic and syndromic pancreatic islet cell tumorsZoran Erlic, Ursula Ploeckinger, Alberto Cascon, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2007
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1Birke Bausch, Wiktor Borozdin, Victor F Mautner, et al.
Endocrine-Related Cancer|September 22, 2016
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegalyIulia Potorac, Patrick Petrossians, Adrian F Daly, et al.
Annales D'Endocrinologie|February 5, 2026
Prevalence, risk factors and management of bone complications in Cushing`s syndrome across Europe. Data from the European Registry on Cushing's syndrome (ERCUSYN)Aleksandra Zdrojowy-Wełna, Claudia Amaral, Marta Araujo-Castro, et al.
JAMA Oncology|April 7, 2017
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed PreventionBirke Bausch, Francesca Schiavi, Ying Ni, et al.
Pageof 59